Page last updated: 2024-09-05

17 alpha-hydroxyprogesterone caproate and Local Neoplasm Recurrence

17 alpha-hydroxyprogesterone caproate has been researched along with Local Neoplasm Recurrence in 6 studies

Research

Studies (6)

TimeframeStudies, this research(%)All Research%
pre-19904 (66.67)18.7374
1990's0 (0.00)18.2507
2000's1 (16.67)29.6817
2010's1 (16.67)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Brockbank, E; Bryant, A; Gallagher, C; Kokka, F; Oram, D1
CROWLEY, LG; MACDONALD, I1
Aoki, D; Banno, K; Nozawa, S; Susumu, N; Suzuki, A; Suzuki, N; Tamada, Y1
Botnar', ER; Chernyĭ, AP; Shendereva, TS; Shvedova, LA; Volostnykh, LV1
Abeler, V; Kjørstad, K; Kolstad, P; Vergote, I1
Decker, DG; Edmonson, JH; Jefferies, JA; Malkasian, GD; O'Brien, PC; Podratz, KC1

Reviews

2 review(s) available for 17 alpha-hydroxyprogesterone caproate and Local Neoplasm Recurrence

ArticleYear
Hormonal therapy in advanced or recurrent endometrial cancer.
    The Cochrane database of systematic reviews, 2010, Dec-08, Issue:12

    Topics: 17 alpha-Hydroxyprogesterone Caproate; Adult; Antineoplastic Agents, Hormonal; Disease-Free Survival; Drug Therapy, Combination; Endometrial Neoplasms; Female; Humans; Hydroxyprogesterones; Medroxyprogesterone Acetate; Megestrol; Neoplasm Recurrence, Local; Neoplasm Staging; Progestins

2010
[Conservative hormonal therapy for endometrial cancer].
    Nihon rinsho. Japanese journal of clinical medicine, 2004, Volume: 62 Suppl 10

    Topics: 17 alpha-Hydroxyprogesterone Caproate; Antineoplastic Agents, Hormonal; Endometrial Neoplasms; Female; Humans; Hydroxyprogesterones; Medroxyprogesterone Acetate; Megestrol Acetate; Neoplasm Recurrence, Local; Neoplasm Staging; Treatment Outcome

2004

Trials

1 trial(s) available for 17 alpha-hydroxyprogesterone caproate and Local Neoplasm Recurrence

ArticleYear
A randomized trial of adjuvant progestagen in early endometrial cancer.
    Cancer, 1989, Sep-01, Volume: 64, Issue:5

    Topics: 17 alpha-Hydroxyprogesterone Caproate; Adenocarcinoma; Clinical Trials as Topic; Combined Modality Therapy; Estrogen Antagonists; Female; Humans; Hydroxyprogesterones; Neoplasm Recurrence, Local; Progesterone Congeners; Prognosis; Random Allocation; Risk Factors; Uterine Neoplasms

1989

Other Studies

3 other study(ies) available for 17 alpha-hydroxyprogesterone caproate and Local Neoplasm Recurrence

ArticleYear
DELALUTIN AND ESTROGENS FOR THE TREATMENT OF ADVANCED MAMMARY CARCINOMA IN THE POSTMENOPAUSAL WOMAN.
    Cancer, 1965, Volume: 18

    Topics: 17 alpha-Hydroxyprogesterone Caproate; Breast Neoplasms; Diethylstilbestrol; Drug Therapy; Estradiol; Estrogens; Female; Geriatrics; Humans; Hydroxyprogesterones; Menopause; Neoplasm Metastasis; Neoplasm Recurrence, Local; Neoplasms; Pathology; Postmenopause

1965
[Combined morphologic evaluation of the efficacy of progestin therapy of primary endometrial cancer].
    Voprosy onkologii, 1984, Volume: 30, Issue:3

    Topics: 17 alpha-Hydroxyprogesterone Caproate; Adenocarcinoma; Biopsy; Carcinoma, Squamous Cell; Combined Modality Therapy; Female; Humans; Hydroxyprogesterones; Neoplasm Recurrence, Local; Time Factors; Uterine Neoplasms

1984
Effects of progestational agents in treatment of endometrial carcinoma.
    Obstetrics and gynecology, 1985, Volume: 66, Issue:1

    Topics: 17 alpha-Hydroxyprogesterone Caproate; Female; Humans; Hydroxyprogesterones; Medrogestone; Megestrol; Neoplasm Recurrence, Local; Progesterone Congeners; Prognosis; Time Factors; Uterine Neoplasms

1985